International Profile: CancerWorld Honors Prof. Michael Gnant
From Surgeon to Global Mentor
10.03.2026
CancerWorld, published by OncoDaily, features ABCSG-president Michael Gnant in its latest issue, highlighting his influential contribution to modern breast cancer research and treatment. The article portrays a physician-scientist who has repeatedly challenged established routines and encouraged critical thinking in clinical practice.
Special attention is also given to the development of ABCSG, which has evolved from a relatively lean academic network into a highly structured, internationally established platform for clinical trials.
Beyond scientific progress, the profile addresses key challenges and developments in modern oncology: the importance of evidence-based treatment de-escalation, new perspectives through biomarkers such as circulating tumor DNA, and the responsible use of emerging technologies such as artificial intelligence. It also raises structural issues, including the limited public funding of clinical research in Europe and the growing administrative burden in clinical trials.
The article further highlights the increasing role of well-informed and actively involved patients. Trust, transparent communication and shared decision-making have become essential elements of modern cancer care.
The profile ultimately recognizes a physician and researcher who has repeatedly been willing to ask uncomfortable questions – and who insists that medical progress should not only be measured by what medicine can do, but also by what is truly beneficial for patients.
The full article was published in CancerWorld, Issue #113 (03/2026).
Share on